Active senior woman jogging outdoors with water bottle, supporting bone health through regular exercise

Bone health rarely feels urgent, until a doctor mentions a DEXA scan or a diagnosis of osteopenia or osteoporosis. In truth, your bones have been changing quietly for decades before that conversation happens. Understanding postmenopausal women bone loss, and what happens to bone density long before menopause even begins, can help you make more informed decisions about your long-term health. At Marodyne, we hear from women across Canada at every stage of this process. Some are newly perimenopausal and curious about prevention. Others are years past menopause and searching for a drug-free bone health device to add to their care plan. Here is what the research says about bone health at every age, and where support like Marodyne LiV may fit in.

How Bone Remodeling Works Before Menopause

Bone is living tissue. Throughout life, it goes through a continuous cycle called bone remodeling, in which old bone is broken down and new bone is formed in its place. Cells called osteoclasts remove old bone tissue, while osteoblasts build new bone. In healthy bone turnover, these two processes stay roughly balanced.

Most people reach their peak bone mass by their early thirties. From that point on, bone density gradually and naturally declines, even before any signs of menopause appear. Diet, weight-bearing activity, and genetics all influence how much bone mass a person builds early in life, and how well that foundation holds up over time. Supporting bone health before menopause is one of the most useful things a woman can do for her long-term skeletal health.

What Happens to Bone Density After Menopause

Menopause changes the picture significantly. When estrogen levels drop, bone breakdown speeds up while bone building struggles to keep pace, leading to a period of more rapid bone loss.1 The greatest decline usually happens in the first ten years after a woman’s final period, after which the rate of loss tends to slow.1

Estrogen plays a central role in protecting bone throughout life, and its decline at menopause is strongly linked to lower bone mineral density and a higher risk of fracture.2 This is part of why osteopenia and osteoporosis become more common in the years following menopause. Many of the women we support at Marodyne come to us after a DEXA scan has shown lower than expected bone density, often before they have any noticeable symptoms. If that sounds familiar, our patients page outlines the options available to you.

Non-Drug Ways to Support Bone Health at Every Age

Whether you are years away from menopause or well past it, several lifestyle factors may help support bone health:

  • Getting enough calcium and vitamin D through diet or, if recommended by your doctor, supplementation
  • Weight-bearing and resistance exercise, which may help stimulate osteoblast activity
  • Avoiding smoking and limiting alcohol intake, both of which are linked to lower bone density
  • Scheduling regular DEXA scans to track bone density changes over time

For women looking for additional non-drug support, low intensity vibration devices have become an area of growing interest. A bone health device such as Marodyne LiV uses a specific, low-amplitude signal designed for bone stimulation rather than general muscle toning.

Active seniors stretching outdoors together, supporting bone health through regular weight-bearing exercise

How Marodyne LiV Supports Bone Health After Menopause

Marodyne LiV is a certified, drug-free bone health device developed with input from NASA research into bone loss in astronauts, detailed further on our story page. Standing on the platform for 10 to 20 minutes a day delivers a gentle, low-amplitude vibration signal that may help stimulate osteoblast activity and support bone density over time.

It is not a medication, and it does not replace guidance from your healthcare provider. Many women use Marodyne LiV alongside prescribed treatment, while others use it as a standalone, drug-free option with their doctor’s support. Like most approaches to bone health, consistency matters. Clinical research suggests that regular daily use over 12 to 18 months may support measurable improvements.

Frequently Asked Questions

What is the difference between osteopenia and osteoporosis?

Osteopenia means bone density is lower than normal, but not low enough to be classified as osteoporosis. Osteoporosis reflects a more advanced stage of bone loss with a higher fracture risk. A DEXA scan is typically used to identify both.

How can I improve bone density after 50?

Adequate calcium and vitamin D, regular weight-bearing exercise, and avoiding smoking can all help support bone health after 50. Some women also add a non-drug bone health device such as Marodyne LiV to their routine. Your healthcare provider can help you build a plan suited to your needs.

Does a vibration device for osteopenia actually work?

Low intensity vibration devices like Marodyne LiV deliver a specific signal aimed at bone stimulation, unlike general fitness vibration plates. Research suggests this approach may help support bone density and muscle strength when used consistently over time. It works best as part of a broader bone health plan.

Is Marodyne LiV safe to use after menopause?

Yes. Marodyne LiV is non-invasive, has no known side effects, and is designed for home use. Many of the women we support are postmenopausal and use it alongside their existing care, and our patients page outlines what to expect if you are considering it.

When should I get a DEXA scan?

Many women are advised to have a baseline DEXA scan around the time of menopause, particularly if they have risk factors for osteoporosis. Your doctor can recommend a schedule based on your personal and family health history.

Take the Next Step Toward Stronger Bones

Ready to find out if Marodyne LiV is right for you? Speak With Our Team and we will walk you through cost, insurance, and prescription options.

References

  1. Osteoporosis Canada. Menopause and Bone Health. osteoporosis.ca.
  2. Sacco SM, Ward WE. Revisiting Estrogen: Efficacy and Safety for Postmenopausal Bone Health. J Osteoporos. 2010;2010:708931. doi:10.4061/2010/708931